4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-004922
Chief Financial Officer sold 3,500 shares at $11.05 ($38,675)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-01-24 | Sale | −3,500 | $11.05 | $38,675 | 76,132 | D |
| Open-market sales · 3,500 sh · avg $11.05 · $38,675 | |||||||
Loading xslF345X03/doc4.xml…